We are live on
!
Find out more
CS
Credit Suisse Portfolio holdings
AUM
$104B
1-Year Est. Return
34.76%
This Fund
S&P 500
This Quarter
Est. Return
+3.9%
1 Year Est. Return
+34.76%
3 Year Est. Return
+49.35%
5 Year Est. Return
+181.01%
10 Year Est. Return
+395.52%
AUM
$113B
AUM Growth
+$3.29B
(+3%)
Cap. Flow
+$309M
Cap. Flow
% of AUM
0.27%
Top 10 Holdings %
Top 10 Hldgs %
17.16%
Holding
4,363
New
403
Increased
1,677
Reduced
1,774
Closed
295
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alcon
ALC
|
+$603M |
| 2 |
Entergy
ETR
|
+$403M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$386M |
| 4 |
iShares China Large-Cap ETF
FXI
|
+$296M |
| 5 |
CELG
Celgene Corp
CELG
|
+$294M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.67B |
| 2 |
AABA
Altaba Inc
AABA
|
+$373M |
| 3 |
iShares Core MSCI Total International Stock ETF
IXUS
|
+$232M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$229M |
| 5 |
IBM
IBM
|
+$218M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 10.95% |
| 2 | Healthcare | 10.9% |
| 3 | Financials | 9.6% |
| 4 | Consumer Discretionary | 6.43% |
| 5 | Industrials | 6.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SNBR
2801
DELISTED
Sleep Number
SNBR
| $1.11M | ﹤0.01% |
27,405
-1,903
| -6% | -$73.5K |
|
|
MRO
2802
CALL
DELISTED
Marathon Oil Corporation
MRO
| $1.11M | ﹤0.01% |
77,800
-98,200
| -56% | -$1.52M |
|
2803
Northern Oil and Gas
NOG
$2.3B
| $1.1M | ﹤0.01% |
57,115
-2,614
| -4% | -$60.4K |
|
2804
SPS Commerce
SPSC
$2.69B
| $1.1M | ﹤0.01% |
21,572
-16,458
| -43% | -$858K |
|
2805
PUT
Hershey
HSY
$35.5B
| $1.1M | ﹤0.01% |
+8,200
| New | +$1.04M |
|
2806
Inogen
INGN
$175M
| $1.1M | ﹤0.01% |
16,426
-22,053
| -57% | -$1.68M |
|
2807
Levi Strauss
LEVI
$9.44B
| $1.1M | ﹤0.01% |
+52,557
| New | +$1.16M |
|
2808
US Physical Therapy
USPH
$1.2B
| $1.09M | ﹤0.01% |
8,929
-417
| -4% | -$47.9K |
|
2809
CALL
RTX Corp
RTX
$290B
| $1.09M | ﹤0.01% |
13,348
-105,350
| -89% | -$8.81M |
|
2810
Enpro
NPO
$6.63B
| $1.09M | ﹤0.01% |
17,104
-6,943
| -29% | -$454K |
|
2811
STAAR Surgical
STAA
$1.21B
| $1.09M | ﹤0.01% |
37,182
-32,562
| -47% | -$940K |
|
|
TGI
2812
DELISTED
Triumph Group
TGI
| $1.09M | ﹤0.01% |
47,523
-20,597
| -30% | -$443K |
|
2813
Central Garden & Pet Co Class A
CENTA
$2.37B
| $1.09M | ﹤0.01% |
55,183
+12,454
| +29% | +$250K |
|
2814
Pilgrim's Pride
PPC
$6.51B
| $1.08M | ﹤0.01% |
42,720
+8,595
| +25% | +$223K |
|
2815
Artisan Partners
APAM
$2.79B
| $1.08M | ﹤0.01% |
39,412
+459
| +1% | +$12.2K |
|
|
RARX
2816
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
| $1.08M | ﹤0.01% |
36,093
-18,634
| -34% | -$427K |
|
|
NXGN
2817
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
| $1.08M | ﹤0.01% |
54,359
+2,943
| +6% | +$55K |
|
|
NP
2818
DELISTED
Neenah, Inc. Common Stock
NP
| $1.08M | ﹤0.01% |
16,008
+1,261
| +9% | +$79.6K |
|
2819
Allegiant Air
ALGT
$2.64B
| $1.08M | ﹤0.01% |
7,517
+1,578
| +27% | +$221K |
|
|
VRTU
2820
DELISTED
Virtusa Corporation
VRTU
| $1.08M | ﹤0.01% |
24,310
+4,426
| +22% | +$216K |
|
|
NCI
2821
DELISTED
Navigant Consulting, Inc.
NCI
| $1.07M | ﹤0.01% |
46,269
-38,642
| -46% | -$855K |
|
|
SEM
2822
DELISTED
Select Medical
SEM
| $1.07M | ﹤0.01% |
125,453
-25,761
| -17% | -$204K |
|
|
KNL
2823
DELISTED
Knoll, Inc.
KNL
| $1.07M | ﹤0.01% |
46,411
-3,310
| -7% | -$68.6K |
|
2824
AZZ Inc
AZZ
$4.35B
| $1.06M | ﹤0.01% |
23,134
-99
| -0.4% | -$4.43K |
|
2825
Cactus
WHD
$5.21B
| $1.06M | ﹤0.01% |
32,138
-3,054
| -9% | -$106K |
|
Similar funds
CSIA
CAN
VAM
CA
MNG
DPAM
ICG
CW
Credit Suisse's Q2 2019 Portfolio in Review
As of Q2 2019, Credit Suisse held 4,363 positions worth $113B, up 3% from $110B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Credit Suisse's Q2 2019 filing shows 403 new, 1,677 increased, 1,774 reduced and 295 closed positions. Its largest new stake was Alcon: 10,270,934 shares worth $637M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.67B.
By sector, the portfolio is most concentrated in Technology at 11% of assets, down from 11% a quarter earlier, followed by Healthcare and Financials.
- Credit Suisse's largest Q2 2019 buy was Alcon: 10,270,934 shares worth $637M.
- Credit Suisse added most to Entergy in Q2 2019, an estimated $403M increase.
- Credit Suisse's biggest Q2 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.67B.
- Credit Suisse fully exited iShares Core MSCI Total International Stock ETF in Q2 2019, selling an estimated $232M.
- Credit Suisse's ten largest holdings make up 17% of its $113B portfolio in Q2 2019.
- Credit Suisse opened 403 new positions and closed 295 in Q2 2019.
- Credit Suisse's portfolio value rose 3% quarter-over-quarter to $113B.
Based on Credit Suisse's 13F filing for Q2 2019, filed 14 Aug 2019.